Dermatology Archives - Open Health

Weighing the Evidence: JAK Safety, OX40/OX40L Biology, and the Medical Communications Gap in Dermatology

OPEN Health has worked across therapeutic areas long enough to see the same failure mode recur: prescribers get safety data they lack the framework to weigh, and may default to caution that...

The evolution of biologics: Why mechanism differentiation is now the central communications challenge in dermatology

The biologic era in dermatology has reached maturity. The question that once dominated clinical conversations— “Are biologics better than corticosteroids?”—has been answered. Today’s conversations are more complex: comparative efficacy in biologic-experienced patients,...

A cost-effectiveness analysis of deucravacitinib vs. apremilast in moderate-to-severe psoriasis patients in Japan

Authors: G van de Wetering, H Kim, D Roberts, Y Hikichi, M Smith, Y Tada Published: Journal of Medical Economics, 2025 View publication Objective This study aimed to evaluate the cost-effectiveness of...

Economic and humanistic burden in paediatric patients with atopic dermatitis

Authors: R Achten, L Van der Rijst, M Piena, H Lamers, F De Beer, M De Bruin-Weller, M De Graaf Published: Acta Dermato-Venereologica, 2023 View publication Abstract Data concerning the economic and...

Development and validation of a photonumeric scale to assess marionette lines

Authors: N Kefalas, S R D Cueto, F Urdiales-Gálvez, L Barry, A Gritti, A Marchac, M Lim, C de la Guardia, G Kerson, M Silberberg Published: Dermatologic Surgery: Official Publication for American...

Assessing response in atopic dermatitis: A systematic review of the psychometric performance of measures used in HTAs and clinical trials

Authors: H Penton, S Jayade, S Selveindran, M Heisen, C Piketty, L Ulianov, Z K Jabbar-Lopez, J I Silverberg & J Puelles Published: Dermatology and Therapy, 2023 View publication Introduction Assessing treatment...

Matching-adjusted indirect comparison of the long-term efficacy of deucravacitinib versus adalimumab for moderate to severe plaque psoriasis

Authors: A W Armstrong, S H Park, V Patel, M Hogan, W-J Wang, D Davidson, V Chirikov Published: Dermatology and Therapy, 2023 View publication Introduction Deucravacitinib, an oral tyrosine kinase 2 (TYK2)...

Going paperless: a new era for patient-reported outcome measures in dermatology

Authors: C J Bottomley Published: The British journal of dermatology, 2017 View publication No abstract available

Cost-effectiveness of partially hydrolyzed whey protein formula in the primary prevention of atopic dermatitis in at-risk urban Filipino infants

Authors: M Botteman, P Detzel Published: Value in Health Regional Issues, 2014 View publication Background Atopic dermatitis (AD) is one of the most common skin conditions among infants. Proteins found in cow’s...

News